Overview
Beyond Anti-Angiogenesis
Origins of Vascular Targeting Agents
Vascular Targeting
Abnormal Vasculature
ZYBRESTAT Background
How Our Drugs Work
Overview
ZYBRESTAT in ATC
ZYBRESTAT in NSCLC
ZYBRESTAT in Ovarian Cancer
ZYBRESTAT for Ophthalmology
OXi4503
Vascular Disrupting Technology
Clinical Trials
Overview
Stock Quote
Management
Corporate Governance
Financial Fact Sheet
Annual Reports
SEC Filings
Press Releases
Investor FAQs
Events & Presentations
Contact IR
Requested Printed Materials
Investor Alert Sign-up
Overview
Management
Board of Directors
Advisory Board
Alliances & Partners
Contact
Overview
News Articles
Press Releases
Events & Presentations
Publications & Posters
Working at OXiGENE
Open Job Opportunities
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Home
>
Corporate
>
Board of Directors
>
Chaplin
Chaplin
Next Profile
Product Pipeline
OXiGENE Clinical Trials
Investor Center
© 2009 OXiGENE, Inc.
Text Size
A
A
A
Home
Terms of Use
Copyright & Trademark
Privacy Policy
